Literature DB >> 19057388

Age-specific incidence of breast cancer in breast cancer survivors and their first-degree relatives.

Lisbeth Bertelsen1, Lene Mellemkjaer, Jane Christensen, Rajesh Rawal, Jørgen H Olsen.   

Abstract

BACKGROUND: The incidence rate of breast cancer in first-degree relatives of women with breast cancer has been hypothesized to become constant at a predetermined age in accordance with observations of a high, roughly constant incidence rate of contralateral breast cancer by age. We attempted to test this hypothesis in the Danish population with cancer registry data.
METHODS: We determined the age-specific incidence rates of contralateral breast cancer in Danish women who had a first breast cancer before they were 50 years of age and the rates of breast cancer among their first-degree female relatives during 1943 to 1999. The observed rates were tested for trends chi test or evaluated in Cox proportional hazard models.
RESULTS: A high incidence rate of contralateral breast cancer was observed in women aged 25-44 years, followed by a decreasing rate, which reached a level corresponding to the rate per breast in the general female population at age 65. At ages older than the index patients age at diagnosis, their first-degree female relatives showed significantly increasing incidence rates of breast cancer by age, with a relatively constant absolute difference of 187 breast cancers per 100,000 person-years between the observed rates and the expected rates.
CONCLUSION: The rate of contralateral breast cancer is particular high at young ages but the excess ebbs as the cohort ages, perhaps due to elimination of predisposed individuals at early ages from the cohort of survivors. First-degree relatives seem to share breast cancer susceptibility genes with the family proband resulting in a constant excess rate of breast cancer throughout life.

Entities:  

Mesh:

Year:  2009        PMID: 19057388     DOI: 10.1097/EDE.0b013e318190eee6

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  4 in total

Review 1.  Is symptom-oriented follow-up still up to date?

Authors:  Christoph Mundhenke; Volker Moebus
Journal:  Breast Care (Basel)       Date:  2013-10       Impact factor: 2.860

2.  Declining incidence of contralateral breast cancer in the United States from 1975 to 2006.

Authors:  Hazel B Nichols; Amy Berrington de González; James V Lacey; Philip S Rosenberg; William F Anderson
Journal:  J Clin Oncol       Date:  2011-03-14       Impact factor: 44.544

3.  High constant incidence rates of second primary cancers of the head and neck: a pooled analysis of 13 cancer registries.

Authors:  Cristina Bosetti; Ghislaine Scelo; Shu-Chun Chuang; Jon M Tonita; Sharon Tamaro; Jon G Jonasson; Erich V Kliewer; Kari Hemminki; Elisabete Weiderpass; Eero Pukkala; Elizabeth Tracey; Jorgen H Olsen; Vera Pompe-Kirn; David H Brewster; Carmen Martos; Kee-Seng Chia; Paul Brennan; Mia Hashibe; Fabio Levi; Carlo La Vecchia; Paolo Boffetta
Journal:  Int J Cancer       Date:  2010-11-09       Impact factor: 7.396

4.  Estrogen receptor status in relation to risk of contralateral breast cancer-a population-based cohort study.

Authors:  Maria E C Sandberg; Per Hall; Mikael Hartman; Anna L V Johansson; Sandra Eloranta; Alexander Ploner; Kamila Czene
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.